Results 51 to 60 of about 23,616 (164)

biopharmaceutics

Citation: 'biopharmaceutics' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.15156 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2

npj Vaccines
The COVID-19 pandemic spurred mRNA vaccine innovation, but new SARS-CoV-2 variants highlight the need for vaccines with improved potency and durability.
Jason P. Laliberte, Yingyun Cai, Tara Kenny, Yi Zhang, Kuishu Ren, Kim Rosenthal, Daniel Flores, Richard Roque, Oliver Acton, Vanessa Cadevilla Peano, Noel Janney, Vinita Puri, Sarah Siddiqui, Angela Pack, Giune Padilla, Seme Diallo, Hibret Adissu, Rakesh Choudhary, Hawley Pruitt, Yi-Han Cheng, George Thom, Michael Newton, Cheyne Kurokawa, Johnathan Guest, Phillip Swanson, Yueh-Ming Loo, Joseph R. Francica, Wade Blair, Mark Esser   +28 more
doaj   +1 more source

Biopharmaceuticals: Priority Sector Report

, 2019
The Biopharmaceuticals emerging industry is the result of an evolution of the traditional pharmaceutical industry that emerged in the late 1800s, mainly based on chemical production. The industry has incorporated the more recent emergence of biotechnology developed on living cells and molecules, stemming from key innovations in the 1970s and 1980s ...
openaire   +2 more sources

Reply to "Understanding the Assumptions on Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis". [PDF]

Clin Pharmacol Ther
Almquist J, Chia YL, Tummala R, Bertagnolli L, Jayne D, Tang W, Lindholm C.   +6 more
europepmc   +1 more source

Biopharmaceutics [PDF]

, 2020
openaire   +1 more source

Incidence and prevalence of hypereosinophilic syndrome in the United States: A retrospective claims database study. [PDF]

World Allergy Organ J
Ding B, Pongdee T, Dolin P, Jain P, Most JF, Taylor D, Owen R, Licona L, Ubillos I, Méndez I, Yanjing Chen S.   +10 more
europepmc   +1 more source

Approval lag and loss for biologic-device combination products in Japan and the United States. [PDF]

Front Med Technol
Mochizuki M, Maeda H.
europepmc   +1 more source

Advances in recombinant protein bioprocessing: integrating technological innovation and environmental sustainability. [PDF]

Biotechnol Lett
de Freitas Trindade Mota M, Carvalho Pacheco LG, Piedrahita Aguirre CA, de Magalhães Cabral Albuquerque EC.   +3 more
europepmc   +1 more source

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. [PDF]

Nat Med
Ogbogu PU, Roufosse F, Akuthota P, Kuna P, Groh M, Reiter A, Yokota A, Siddiqui SH, Mutsaers PGNJ, Li B, Khoury P, Bahadori LM, Bednarczyk A, Bouma G, Brooks LG, Ferreira J, Grindebacke H, Ho CN, Jain P, Palmer RL, Jison ML, Klion AD, NATRON study group.   +22 more
europepmc   +1 more source

Biopharmaceutics

Journal of Pharmacy and Pharmacology, 2006
openaire   +2 more sources